Benzinga Quick Stats: Merus IPO
May 20, 2016 at 13:13 PM EDT
Merus BV (NYSE: MRUS) is an immuno-oncology company that develops antibody therapeutics. Initial range for 4.33 million shares at ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.